113 related articles for article (PubMed ID: 29234595)
1. Ibrutinib as a bridge to transplant in high-risk chronic lymphocytic leukemia: A case report and review of the literature.
Annalisa A; Simona B; Lara P; Elena T; Filippo MC; Angela R; Luca Z; Daniele V
Leuk Res Rep; 2017; 8():21-23. PubMed ID: 29234595
[TBL] [Abstract][Full Text] [Related]
2. Treatment of Chronic Lymphocytic Leukemia With del(17p)/TP53 Mutation: Allogeneic Hematopoietic Stem Cell Transplantation or BCR-Signaling Inhibitors?
Montserrat E; Dreger P
Clin Lymphoma Myeloma Leuk; 2016 Aug; 16 Suppl():S74-81. PubMed ID: 27521330
[TBL] [Abstract][Full Text] [Related]
3. The evolving role of hematopoietic cell transplantation in chronic lymphocytic leukemia.
Davids MS; Alyea EP
Curr Hematol Malig Rep; 2015 Mar; 10(1):18-27. PubMed ID: 25682168
[TBL] [Abstract][Full Text] [Related]
4. The Difficult-to-Treat del 17 p Patient-A Case Report in Chronic Lymphocytic Leukemia.
Moldovianu AM; Crisan AM; Varady Z; Coriu D
Medicina (Kaunas); 2021 Dec; 58(1):. PubMed ID: 35056341
[TBL] [Abstract][Full Text] [Related]
5. Clinical Practice Recommendations for Use of Allogeneic Hematopoietic Cell Transplantation in Chronic Lymphocytic Leukemia on Behalf of the Guidelines Committee of the American Society for Blood and Marrow Transplantation.
Kharfan-Dabaja MA; Kumar A; Hamadani M; Stilgenbauer S; Ghia P; Anasetti C; Dreger P; Montserrat E; Perales MA; Alyea EP; Awan FT; Ayala E; Barrientos JC; Brown JR; Castro JE; Furman RR; Gribben J; Hill BT; Mohty M; Moreno C; O'Brien S; Pavletic SZ; Pinilla-Ibarz J; Reddy NM; Sorror M; Bredeson C; Carpenter P; Savani BN
Biol Blood Marrow Transplant; 2016 Dec; 22(12):2117-2125. PubMed ID: 27660167
[TBL] [Abstract][Full Text] [Related]
6. Managing high-risk CLL during transition to a new treatment era: stem cell transplantation or novel agents?
Dreger P; Schetelig J; Andersen N; Corradini P; van Gelder M; Gribben J; Kimby E; Michallet M; Moreno C; Stilgenbauer S; Montserrat E;
Blood; 2014 Dec; 124(26):3841-9. PubMed ID: 25301705
[TBL] [Abstract][Full Text] [Related]
7. [Chronic lymphocytic leukemia: biology, disease progression, and current treatment strategies].
Yano T
Rinsho Ketsueki; 2017; 58(10):1960-1972. PubMed ID: 28978838
[TBL] [Abstract][Full Text] [Related]
8. Progressive chronic lymphocytic leukemia after allogeneic hematopoietic cell transplantation.
Jitawatanarat P; Desai A; Sharda P; Liu H; Ross M; Hernandez-Llizaliturri FJ; McCarthy PL; Chen GL
J Natl Compr Canc Netw; 2012 Oct; 10(10):1203-6. PubMed ID: 23054874
[TBL] [Abstract][Full Text] [Related]
9. Chronic lymphocytic leukemia: 2020 update on diagnosis, risk stratification and treatment.
Hallek M
Am J Hematol; 2019 Nov; 94(11):1266-1287. PubMed ID: 31364186
[TBL] [Abstract][Full Text] [Related]
10. Successful Treatment of Richter Transformation with Ibrutinib in a Patient with Chronic Lymphocytic Leukemia following Allogeneic Hematopoietic Stem Cell Transplant.
Master S; Leary C; Takalkar A; Coltelingam J; Mansour R; Mills GM; Koshy N
Case Rep Oncol; 2017; 10(2):534-541. PubMed ID: 28690529
[TBL] [Abstract][Full Text] [Related]
11. Bruton tyrosine kinase inhibition in chronic lymphocytic leukemia.
Maddocks K; Jones JA
Semin Oncol; 2016 Apr; 43(2):251-9. PubMed ID: 27040703
[TBL] [Abstract][Full Text] [Related]
12. Prognostic and therapeutic stratification in CLL: focus on 17p deletion and p53 mutation.
Buccheri V; Barreto WG; Fogliatto LM; Capra M; Marchiani M; Rocha V
Ann Hematol; 2018 Dec; 97(12):2269-2278. PubMed ID: 30315344
[TBL] [Abstract][Full Text] [Related]
13. Baseline Characteristics Predicting Very Good Outcome of Allogeneic Hematopoietic Cell Transplantation in Young Patients With High Cytogenetic Risk Chronic Lymphocytic Leukemia - A Retrospective Analysis From the Chronic Malignancies Working Party of the EBMT.
van Gelder M; Ziagkos D; de Wreede L; van Biezen A; Dreger P; Gramatzki M; Stelljes M; Andersen NS; Schaap N; Vitek A; Beelen D; Lindström V; Finke J; Passweg J; Eder M; Machaczka M; Delgado J; Krüger W; Raida L; Socié G; Jindra P; Afanasyev B; Wagner E; Chalandon Y; Henseler A; Schoenland S; Kröger N; Schetelig J;
Clin Lymphoma Myeloma Leuk; 2017 Oct; 17(10):667-675.e2. PubMed ID: 28694085
[TBL] [Abstract][Full Text] [Related]
14. Where does allogeneic stem cell transplantation fit in the treatment of chronic lymphocytic leukemia?
Dreger P; Montserrat E; ;
Curr Hematol Malig Rep; 2015 Mar; 10(1):59-64. PubMed ID: 25651976
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of Chronic Lymphocytic Leukemia with TP53 Aberrations].
Lysák D; Schwarz J
Klin Onkol; 2015; 28 Suppl 3():3S39-44. PubMed ID: 26489500
[TBL] [Abstract][Full Text] [Related]
16. BCR Signaling Inhibitors: an Overview of Toxicities Associated with Ibrutinib and Idelalisib in Patients with Chronic Lymphocytic Leukemia.
Falchi L; Baron JM; Orlikowski CA; Ferrajoli A
Mediterr J Hematol Infect Dis; 2016; 8(1):e2016011. PubMed ID: 26977270
[TBL] [Abstract][Full Text] [Related]
17. Current Treatment of Chronic Lymphocytic Leukemia.
Jamroziak K; Puła B; Walewski J
Curr Treat Options Oncol; 2017 Jan; 18(1):5. PubMed ID: 28185174
[TBL] [Abstract][Full Text] [Related]
18. The magnitude of improvement in progression-free survival with targeted therapy in relapsed/refractory chronic lymphocytic leukemia based on prognostic risk category: a systematic review and meta-analysis.
Molica S; Giannarelli D; Mirabelli R; Levato L; Shanafelt TD
Leuk Lymphoma; 2019 Jul; 60(7):1644-1649. PubMed ID: 30516079
[TBL] [Abstract][Full Text] [Related]
19. [Chronic lymphocytic leukemia : treatment concepts in transition].
Eichhorst B; Hallek M
Internist (Berl); 2015 Apr; 56(4):374-80. PubMed ID: 25776793
[TBL] [Abstract][Full Text] [Related]
20. [Chronic lymphocytic leukemia: pathophysiology and current therapy].
Takizawa J
Rinsho Ketsueki; 2017; 58(5):471-479. PubMed ID: 28592762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
